SCHEMBL4979246

SCHEMBL4979246

Cc1ccc2c(c1)C1(NC(=O)N(Cc3ccc(-c4csnn4)cc3)C1=O)C(=O)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
NOTUM Q6P988 1/20 0.41
ADAMTS5 Q9UNA0 7/20 0.38
SMN1; SMN2 Q16637 3/20 0.35
HTT P42858 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
PIK3CD O00329 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4259981 0.84 ADAMTS5 (0.45) POLBKMT2ANOTUMADAMTS5TP53
SCHEMBL4979242 0.82 POLB (0.43) POLBKMT2ANOTUMADAMTS5SMN1; SMN2
SCHEMBL4979616 0.77 KMT2A (0.37) POLBKMT2ASMN1; SMN2HTTALDH1A1
SCHEMBL4263873 0.73 AKR1B1 (0.42) ADAMTS5MAPT
SCHEMBL4976844 0.70 KMT2A (0.38) POLBKMT2AHTTMAPTCYP1A2
SCHEMBL4974510 0.69 CNR1 (0.49) POLBKMT2AADAMTS5ALDH1A1KDM4E
SCHEMBL4979970 0.69 AKR1B1 (0.41) POLBKMT2AADAMTS5SMN1; SMN2ALDH1A1
SCHEMBL4979426 0.69 CNR1 (0.51) POLBKMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL4979166 0.69 CYP1A2 (0.39) POLBKMT2AADAMTS5SMN1; SMN2HTT
SCHEMBL4977919 0.67 KMT2A (0.40) POLBKMT2AALDH1A1KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984374-A1 USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2008-10-29 EP claimed
WO-2007091946-A1 USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO claimed